Databases | 1. PubMed 2. Web of Science 3. Google Scholar |
Other sources | 1. Nayyar et al. [23] 2. Tabanero et al. [3] 3. USP DQI country reports [85] 4. WWARN anti-malarial medicine quality surveyor [86] |
Key search terms | Medicine OR drug quality AND survey OR screening Screening: AND poor quality OR counterfeit OR substandard (medicine OR drug) Detection: AND poor quality OR counterfeit OR substandard (medicine OR drug) |
Eligibility criteria | |
 Dates | 1990–2016 |
 Language | English, French |
 Location | Central, South and South East Asia, Sub-Saharan Africa, Central and South America, Pacific Islands |
 Article type | Scientific publications in international peer-reviewed journals and grey literature (reports and surveys) |
 Types of studies | Field surveys in which anti-malarial medicines were assessed for quality, using a screening technique |
 Screening technique and outcome | 1. Screening techniques: tests based on but not restricted to chromatographic and spectrometric techniques with the addition of visual inspection or visual inspection alone 2. Outcome measure (medicine quality) |
 Exclusion criteria | 1. Reviews/Commentaries/Conference Papers/Letters 2. High specification, non-portable technologies (as defined by Kovacs et al. [24] with LMIC score <4b) 3. Feasibility studies 4. Non-anti-malarial medicine assessed for quality alone 5. Only results of either screening or confirmatory tests presented when both undertaken |
 Search dates | January 2016, updated October 2016 |